Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2026-06-05 16:05:07 ET · period of report 2026-06-03 · accession 0001193125-26-259520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:05 | 2026-06-03 | ANIK | Griffin Stephen D. | Pres, CEO, Dir | M - OptEx | — | +12.8K | 49.7K | +35% | — |
| D | 2026-06-05 16:05 | 2026-06-03 | ANIK | Griffin Stephen D. | Pres, CEO, Dir | F - Tax | $14.41 | -3,769 | 46.0K | -8% | -$54.3K |
| D | 2026-06-05 16:05 | 2026-06-03 | ANIK | Griffin Stephen D. | Pres, CEO, Dir | M - OptEx | $0.00 | -12.8K | 12.8K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-03 | M | A | 12,840 | — | 49,742 | D | — | — | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. (F2) Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-06-03 | F | D | 3,769 | $14.41 | 45,973 | D | — | — | (F3) Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026. |
| 3 | Derivative | Restricted Stock Unit | 2026-06-03 | M | D | 12,840 | $0.00 | 12,840 | D | — · — to — | 12,840 Common Stock | (F1) Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. (F4) On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award. (F4) On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award. |